Treating Metastatic HER2-negative Breast Cancer: Oncology Nursing Approaches to Improve Patient Quality of Life
About this episode
This episode reviews emerging data on ADC use for HER2-negative metastatic breast cancer and discusses strategies for managing associated adverse events.
In this enduring CEC ONS Chapter installment, expert faculty will review emerging data on ADC use for HER2-neg MBC and share insights and strategies on the impact of AEs associated with ADC use and approaches to the management of AEs associated with ADCs in this patient population. To learn more: https://www.ceconcepts.com/activity/treating-metastatic-her2-negative-breast-cancer-oncology-nursing-approaches-to-improve-patient-quality-of-life/
More episodes of CEConversations
- A CaseWise™ Webcast: From Research to Real-World: ADCs, IO Combinations, and Sequencing in Metastatic NSCLC
- Exploring the Horizons in Advanced or Recurrent Endometrial Cancer: Practical Considerations and Future Directions for New Treatment Strategies
- Targeting the Pathway: Evolving Roles of MEK Inhibitors in NF1-Associated PN
- Evolving Paradigms in Immuno-Oncology: Optimizing Patient Care Through Innovative Delivery Approaches of Immune Checkpoint Inhibitors
- MEK Inhibitors in Neurofibromatosis Type 1: Nursing Contributions to NF1-PN Management
- Desmoid Tumors in Focus: Early Recognition, Evolving Therapies, and Nursing-Led Care Strategies
Explore listener stats, chart rankings, contacts and more on the CEConversations podcast page.